SNCA and Parkinson disease: Both of the proposed systems for staging in PD are based on the concept that pathological alpha-synuclein aggregation is the fundamental pathological process defining PD; that dopaminergic dysfunction in the midbrain is eventually universally present; and move away from purely clinically-defined syndromes.